SteadyMed raises $30M in private placement

|About: SteadyMed (STDY)|By:, SA News Editor

SteadyMed (NASDAQ:STDY) announces that it has entered into a definitive agreement to sell ~5M ordinary shares and warrants to purchase ~2.5M ordinary shares at a price of $5.90 per share for gross proceeds of ~$30M in a private placement.

Closing date is April 25.

The Company also preparing to file New Drug Application (NDA) for Trevyent this quarter.

Financing will provide capital for Trevyent commercial launch preparation.